Biosenta Inc.
ZRO
CNSX
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | -50.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | -50.00% | |||
| Cost of Revenue | 0.00% | 0.00% | |||
| Gross Profit | -- | -100.00% | |||
| SG&A Expenses | -22.66% | 29.43% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -20.75% | 33.06% | |||
| Operating Income | 20.76% | -33.15% | |||
| Income Before Tax | 7.81% | -6.92% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 7.81% | -6.92% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 7.81% | -6.92% | |||
| EBIT | 20.76% | -33.15% | |||
| EBITDA | 20.79% | -33.22% | |||
| EPS Basic | 5.11% | -7.03% | |||
| Normalized Basic EPS | 5.81% | -7.50% | |||
| EPS Diluted | 5.11% | -7.03% | |||
| Normalized Diluted EPS | 5.81% | -7.50% | |||
| Average Basic Shares Outstanding | -3.13% | 0.34% | |||
| Average Diluted Shares Outstanding | -3.13% | 0.34% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||